Statin use and the risk of biochemical recurrence of prostate cancer after definitive local therapy: a meta-analysis of eight cohort studies

被引:43
|
作者
Scosyrev, Emil [1 ]
Tobis, Scott [1 ]
Donsky, Heather [1 ]
Wu, Guan [1 ]
Joseph, Jean [1 ]
Rashid, Hani [1 ]
Messing, Edward [1 ]
机构
[1] Univ Rochester, Med Ctr, Dept Urol, Rochester, NY 14642 USA
关键词
biochemical recurrence; biochemical failure; prostate cancer; statins; RADICAL PROSTATECTOMY; CLINICAL PRESENTATION; PUBLICATION BIAS; ANTIGEN LEVELS; POPULATION; OUTCOMES; IMPACT; MEN;
D O I
10.1111/j.1464-410X.2012.11527.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
What's known on the subject? and What does the study add? Over the last few years, several observational studies examined the association of statin use with the risk of biochemical recurrence of prostate cancer after definitive local therapy. The objective of our present study was to summarise available evidence on this subject using the method of meta-analysis. Combined evidence from eight cohort studies did not definitively support the hypothesis that statins influence the risk of biochemical recurrence. However, there was considerable disagreement between individual studies in reported findings and conclusions. OBJECTIVE center dot To perform a systematic review and meta-analysis of clinical studies with statin use as the exposure variable and biochemical recurrence after definitive local therapy for prostate cancer as the outcome. METHODS center dot Relevant publications were identified through PubMed/Medline/Embase databases. center dot Pooled estimates of the hazard ratios (HRs) were computed using the inverse-variance weighting approach. center dot Heterogeneity was assessed using the Cochran's Q test. RESULTS center dot We identified a total of eight eligible studies, all based on the retrospective cohort design. Five of these were based on radical prostatectomy (RP) series and three on radiotherapy (RT) series. center dot There was evidence of heterogeneity in the entire set of eight studies (P= 0.002) as well as in the RP series (P= 0.05) and in the RT series (P= 0.01), when these were considered separately. center dot Based on the random effects inverse-variance weighting approach, pooled estimates of the HRs for the risk of biochemical recurrence in statin users v non-users were 0.91 (95% confidence interval [CI] 0.721.13) for the entire set of eight studies, 1.02 (95% CI 0.801.29) for the RP series and 0.71 (95% CI 0.441.16) for the RT series. CONCLUSION center dot The pooled estimates of the HRs were not significantly different from the null value in this meta-analysis; however, evidence of heterogeneity between the studies was present.
引用
收藏
页码:E71 / E77
页数:7
相关论文
共 50 条
  • [41] Statin use and risk of pancreatic cancer: a meta-analysis
    Cui, Xiaobing
    Xie, Yue
    Chen, Min
    Li, Jun
    Liao, Xiaoming
    Shen, Jian
    Shi, Meng
    Li, Wenjing
    Zheng, Haoxuan
    Jiang, Bo
    CANCER CAUSES & CONTROL, 2012, 23 (07) : 1099 - 1111
  • [42] Statin use and risk of bladder cancer: a meta-analysis
    Xiao-long Zhang
    Jiang Geng
    Xiao-peng Zhang
    Bo Peng
    Jian-ping Che
    Yang Yan
    Guang-chun Wang
    Sheng-qiang Xia
    Yan Wu
    Jun-hua Zheng
    Cancer Causes & Control, 2013, 24 : 769 - 776
  • [43] Statin Use and Risk of Pancreatic Cancer An Updated Meta-analysis of 26 Studies
    Zhang, Yun
    Liang, Mingming
    Sun, Chenyu
    Qu, Guangbo
    Shi, Tingting
    Min, Min
    Wu, Yile
    Sun, Yehuan
    PANCREAS, 2019, 48 (02) : 142 - 150
  • [44] Statin use and mortality of patients with prostate cancer: a meta-analysis
    Meng, Yang
    Liao, Yan-Biao
    Xu, Peng
    Wei, Wu-Ran
    Wang, Jia
    ONCOTARGETS AND THERAPY, 2016, 9 : 1689 - 1696
  • [45] Association of Statin Use with the Risk of Incident Prostate Cancer: A Meta-Analysis and Systematic Review
    Xu, Meng-Yao
    An, Ye
    Liu, Chen-Qian
    Xu, Jin-Zhou
    Zhong, Xing-Yu
    Zeng, Na
    Sun, Jian-Xuan
    Xia, Qi-Dong
    Wang, Shao-Gang
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [46] Statin Use after Radical Prostatectomy Reduces Biochemical Recurrence in Men With Prostate Cancer
    Song, Cheryn
    Park, Sejun
    Park, Jinsung
    Shim, Myungsun
    Kim, Aram
    Jeong, In Gab
    Hong, Jun Hyuk
    Kim, Choung-Soo
    Ahn, Hanjong
    PROSTATE, 2015, 75 (02): : 211 - 217
  • [47] Statin Use and the Risk of Prostate-Specific Antigen Recurrence After Radiation Therapy With or Without Hormone Therapy for Prostate Cancer
    D'Amico, Anthony V.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (16) : 2651 - 2652
  • [48] Statin Use and Risk of Prostate Cancer Recurrence in Men Treated With Radiation Therapy
    Gutt, Ruchika
    Tonlaar, Nathan
    Kunnavakkam, Rangesh
    Karrison, Theodore
    Weichselbaum, Ralph R.
    Liauw, Stanley L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (16) : 2653 - 2659
  • [49] Association Between Statin Use and Prognosis of Breast Cancer: A Meta-Analysis of Cohort Studies
    Lv, Hui
    Shi, Ding
    Fei, Min
    Chen, Yu
    Xie, Fei
    Wang, Zhuoyan
    Wang, Ying
    Hu, Peiying
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [50] Adjuvant Chemotherapy in High-Risk Prostate Cancer Patients after Primary Local Therapy: Recurrence, Metastasis, and Survival - A Meta-Analysis
    Zhang, Qiang
    Huang, Jing
    Xie, Chaofan
    Wu, Tao
    UROLOGIA INTERNATIONALIS, 2021, 105 (5-6) : 394 - 401